Multidisciplinary Association For Psychedelic Studies

Rating: 4.9 stars   699 reviews

Address:

1215 Mission Street Santa Cruz CA 95060 USA

Mission:

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results:

MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics:

Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served:

Worldwide

Programs:

Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

2015 Top-Rated Nonprofit
Write a Review
Donate
Invite Reviews Share This Nonprofit

See How 3Hrs Can Help

More Info

831-429-6362
http://maps.org

Promote This Nonprofit

GreatNonprofits badges allow you to raise awareness of your favorite nonprofits on your own web sites!

Review this charity on
GreatNonprofits

Reviews for Multidisciplinary Association For Psychedelic Studies

Role: Client Served
Rating: 5 stars  

5 people found this review helpful

MAPS has the potential to transform our cultural concept of health and health delivery. In addition to focusing on correcting what is "wrong", the techniques MAPS investigates have the potential to inform and guide clients into potential personal and societal improvements.

I've personally experienced the results of this organization in...

anger management and stress reduction therapies, career guidance, and the deserved acquisition of wealth.

If I had to make changes to this organization, I would...

expand fund-raising to address a broader support base.

What I've enjoyed the most about my experience with this nonprofit is...

my tremendous personal growth.

The kinds of staff and volunteers that I met were...

kind, enlightened and personal.

If this organization had 10 million bucks, it could...

end war and poverty.

Ways to make it better...

I had heard about it earlier.

In my opinion, the biggest challenges facing this organization are...

funding and societal acceptance.

One thing I'd also say is that...

the processes are challenging but effective.

When was your last experience with this nonprofit?

2010-6-01

 
Flag review
Review from Guidestar
Rating: 5 stars  

4 people found this review helpful

I have been a member of MAPS for a year now and have been following their work. I am very impressed by this organization, and particularly Dr. Doblin. I feel they have contributed much to our understanding of psychedelics, and helped to open doors which had been shut for many years due mainly to fear and ignorance. I very highly recommend this organization and will continue to put my full support behind their mission.

I've personally experienced the results of this organization in...

Their fine literature and website.

When was your last experience with this nonprofit?

2010-1-01

 
Flag review
Review from Guidestar
Rating: 5 stars  

6 people found this review helpful

MAPS has been an invaluable organization for me and for the world wide community who feel that psychedelic substances must be researched in a medical/meaningful way rather than simply shunned out of existence. MAPS has also helped me to distribute my film, "LSD: Problem Child and Wonder Drug," providing a way in which people like Dr. Albert Hofmann (discoverer of LSD and highly respected medical/pharmaceutical researcher) might influence the public debate on psychedelics in a way which makes us all realize how important such medical research is. As a media presence as well as a fund raising engine for medical research, MAPS has played a unique and important role in the world.

I've personally experienced the results of this organization in...

The way I outlined above.

When was your last experience with this nonprofit?

2010-2-01

 
Flag review
Review from Guidestar